Pulse Biosciences (PLSE) Work In Process (2021 - 2022)

Pulse Biosciences (PLSE) posted Work In Process of $1.8 million for Q2 2022, up 6.68% on a QoQ basis from $1.7 million in Q1 2022.

Analysis

Pulse Biosciences (PLSE) Work In Process (2021 - 2022) Analysis & Trends

Pulse Biosciences has reported Work In Process for 2 years, with the latest figure at $1.8 million in Q2 2022.

On a quarterly basis, Work In Process changed N/A year-over-year to $1.8 million in Q2 2022; TTM through Jun 2022 was $1.8 million, a N/A change from a year earlier, with the FY2021 full-year figure at $1.4 million, changed N/A from the prior year.
Work In Process was $1.8 million for Q2 2022 at Pulse Biosciences, up from $1.7 million in the prior quarter.
The five-year high for Work In Process was $1.8 million in Q2 2022, with the low at $1.2 million in Q3 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn
10	Pulse Biosciences	3.76 Bn	3.76 Bn	161,000.00

Historic Data

Download Data